Cost-Utility Analysis Of Tocilizumab In The Treatment Of Active Systemic Juvenile Idiopathic Arthritis
May 1, 2013, 00:00
10.1016/j.jval.2013.03.1142
https://www.valueinhealthjournal.com/article/S1098-3015(13)01213-8/fulltext
Title :
Cost-Utility Analysis Of Tocilizumab In The Treatment Of Active Systemic Juvenile Idiopathic Arthritis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01213-8&doi=10.1016/j.jval.2013.03.1142
First page :
A225
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
714